Vancomycin disrupts mitochondrial morphology and function and impairs macrophage fungal killing
mBio · 10.06.2026 · 17 (6)
DOI: 10.1128/mbio.00580-26 ↗Kurz gefasst
Fachartikel in der Zeitschrift mBio, erschienen am 10.06.2026. Verfasst von Ebrima Bojang und 16 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Immunology & Immunotherapy, University of Birmingham, Birmingham, United Kingdom. Hauptthemen laut MEDLINE: Vancomycin, Mitochondria, Macrophages, Candida albicans. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Biotechnology and Biological Sciences Research Council, Diabetes UK.
Abstract (Originalsprache)
Vancomycin is a widely prescribed antibiotic used in the treatment of gram-positive bacterial infections. We previously showed that this antibiotic disrupted protective antifungal immune responses via microbiome dysbiosis, enhancing susceptibility to invasive candidiasis. Antibiotics are an independent risk factor for developing this life-threatening fungal infection, but whether microbiota-independent mechanisms also drive this association is not clear. Here, we show that vancomycin directly impairs macrophage responses to Candida albicans , the main causative agent of invasive candidiasis. Vancomycin-treated macrophages were less able to kill C. albicans despite normal phagocytosis rates and were hyper-inflammatory and more likely to die during infection. Using a fluorescently labeled vancomycin, we observed vancomycin uptake by macrophages in vivo and within close proximity to the mitochondrial outer membrane. Vancomycin treatment led to a significant depolarization, reduced respiratory capacity, and a hyper-fragmented morphology of mitochondria, as well as increased cellular ROS production. Taken together, this work demonstrates direct effects of vancomycin on mammalian immune cells, helping us to understand the pro-inflammatory effects of this drug and how it promotes susceptibility to life-threatening fungal infection. IMPORTANCE Antibiotics are widely prescribed drugs used to treat bacterial infections; however, their use may increase the likelihood of developing life-threatening fungal infections in vulnerable patients. Candida albicans is a commensal fungus in humans but may cause serious disease in patients with defined risk factors, including antibiotic exposure. We find that the antibiotic vancomycin significantly impairs the ability of macrophages to kill C. albicans yeast. Vancomycin-induced defects in fungal killing were associated with changes to mitochondria in antibiotic-exposed macrophages, which also exhibited enhanced oxidative stress and reduced survival during fungal infection. This work identifies a direct mechanism by which antibiotics may impair antifungal immunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Immunology & Immunotherapy, University of Birmingham, Birmingham, United Kingdom.
- Department of Genetics and Genome Biology, University of Leicester, Leicester, United Kingdom.
- Research Group Microbial Immunology, Leibniz Institute for Natural Product Research and Infection Biology-Hans Knoell Institute, Jena, Germany.
- Institute of Microbiology & Infection, University of Birmingham, Birmingham, United Kingdom.
- Phenome Centre Birmingham and School of Biosciences, University of Birmingham, Birmingham, United Kingdom.
- Centre for Metabolomics Research, Department of Biochemistry, Cell and Systems Biology, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, United Kingdom.
ORCID-Profile: Ketema Abdissa, Rebecca A Hall, Rebecca A Drummond
Förderung
- Wellcome Trust
- Biotechnology and Biological Sciences Research Council
- Diabetes UK
- British Infection Association
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Bojang, E., Sheriff, L., Morris, E., Rouvray, S., Fu, M. S., Wellings, C., Abdissa, K., Stavrou, V., Clark, C., Southam, A. D., Dunn, W. B., Bending, D., Hombrebueno, J. R., Jacobsen, I., Dimeloe, S., Hall, R. A., & Drummond, R. A. (2026). Vancomycin disrupts mitochondrial morphology and function and impairs macrophage fungal killing. mBio, 17(6). https://doi.org/10.1128/mbio.00580-26
Vancouver
Bojang E, Sheriff L, Morris E, Rouvray S, Fu MS, Wellings C, et al. Vancomycin disrupts mitochondrial morphology and function and impairs macrophage fungal killing. mBio. 2026;17(6). doi:10.1128/mbio.00580-26
BibTeX
@article{Bojang2026,
author = {Bojang, Ebrima and Sheriff, Lozan and Morris, Emma and Rouvray, Sophie and Fu, Man Shun and Wellings, Chloe and Abdissa, Ketema and Stavrou, Victoria and Clark, Callum and Southam, Andrew D and Dunn, Warwick B and Bending, David and Hombrebueno, Jose R and Jacobsen, Ilse and Dimeloe, Sarah and Hall, Rebecca A and Drummond, Rebecca A},
title = {Vancomycin disrupts mitochondrial morphology and function and impairs macrophage fungal killing},
journal = {mBio},
year = {2026},
volume = {17},
number = {6},
doi = {10.1128/mbio.00580-26}
}
EUVIMED